DENTSPLY SIRONA Inc. (XRAY)
USD 13.71
(3.24%)
USD 13.71
(3.24%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.29 Billion USD | 9.84% |
| 2022 | 2.09 Billion USD | -6.56% |
| 2021 | 2.24 Billion USD | -6.94% |
| 2020 | 2.4 Billion USD | 54.8% |
| 2019 | 1.55 Billion USD | -6.18% |
| 2018 | 1.65 Billion USD | 2.84% |
| 2017 | 1.61 Billion USD | 6.65% |
| 2016 | 1.51 Billion USD | 32.44% |
| 2015 | 1.14 Billion USD | -1.03% |
| 2014 | 1.15 Billion USD | -1.14% |
| 2013 | 1.16 Billion USD | -4.57% |
| 2012 | 1.22 Billion USD | -17.98% |
| 2011 | 1.49 Billion USD | 146.68% |
| 2010 | 604.01 Million USD | 56.02% |
| 2009 | 387.15 Million USD | -13.87% |
| 2008 | 449.47 Million USD | -7.0% |
| 2007 | 483.3 Million USD | 30.57% |
| 2006 | 370.15 Million USD | -45.75% |
| 2005 | 682.31 Million USD | -19.99% |
| 2004 | 852.81 Million USD | 5.0% |
| 2003 | 812.17 Million USD | 4.88% |
| 2002 | 774.37 Million USD | 5.91% |
| 2001 | 731.15 Million USD | 562.92% |
| 2000 | 110.29 Million USD | -33.36% |
| 1999 | 165.5 Million USD | -29.21% |
| 1998 | 233.8 Million USD | 80.54% |
| 1997 | 129.5 Million USD | 27.21% |
| 1996 | 101.8 Million USD | 33.42% |
| 1995 | 76.3 Million USD | 248.4% |
| 1994 | 21.9 Million USD | -82.37% |
| 1993 | 124.2 Million USD | 756.55% |
| 1992 | 14.5 Million USD | -53.38% |
| 1991 | 31.1 Million USD | 445.61% |
| 1990 | 5.7 Million USD | 256.25% |
| 1989 | 1.6 Million USD | -11.11% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.21 Billion USD | -3.87% |
| 2024 Q2 | 2.21 Billion USD | 0.09% |
| 2023 Q3 | 2.12 Billion USD | -5.48% |
| 2023 Q4 | 2.29 Billion USD | 8.29% |
| 2023 Q1 | 2.3 Billion USD | 9.99% |
| 2023 Q2 | 2.24 Billion USD | -2.43% |
| 2023 FY | 2.29 Billion USD | 9.84% |
| 2022 Q4 | 2.09 Billion USD | -2.06% |
| 2022 Q1 | 2.37 Billion USD | 6.07% |
| 2022 Q3 | 2.13 Billion USD | -2.24% |
| 2022 Q2 | 2.18 Billion USD | -8.0% |
| 2022 FY | 2.09 Billion USD | -6.56% |
| 2021 Q1 | 2.37 Billion USD | -1.29% |
| 2021 Q4 | 2.24 Billion USD | 1.13% |
| 2021 Q3 | 2.21 Billion USD | -7.32% |
| 2021 FY | 2.24 Billion USD | -6.94% |
| 2021 Q2 | 2.39 Billion USD | 0.59% |
| 2020 Q2 | 2.28 Billion USD | 46.18% |
| 2020 Q3 | 2.33 Billion USD | 2.08% |
| 2020 Q4 | 2.4 Billion USD | 3.24% |
| 2020 FY | 2.4 Billion USD | 54.8% |
| 2020 Q1 | 1.56 Billion USD | 0.49% |
| 2019 FY | 1.55 Billion USD | -6.18% |
| 2019 Q4 | 1.55 Billion USD | 1.36% |
| 2019 Q2 | 1.61 Billion USD | -4.4% |
| 2019 Q3 | 1.53 Billion USD | -5.12% |
| 2019 Q1 | 1.69 Billion USD | 2.05% |
| 2018 Q3 | 1.72 Billion USD | -4.16% |
| 2018 Q2 | 1.8 Billion USD | 9.67% |
| 2018 Q1 | 1.64 Billion USD | 2.1% |
| 2018 Q4 | 1.65 Billion USD | -4.18% |
| 2018 FY | 1.65 Billion USD | 2.84% |
| 2017 Q1 | 1.52 Billion USD | 1.13% |
| 2017 FY | 1.61 Billion USD | 6.65% |
| 2017 Q4 | 1.61 Billion USD | 0.68% |
| 2017 Q3 | 1.6 Billion USD | -0.51% |
| 2017 Q2 | 1.6 Billion USD | 5.29% |
| 2016 Q4 | 1.51 Billion USD | -4.73% |
| 2016 Q3 | 1.58 Billion USD | 35.36% |
| 2016 Q1 | 1.16 Billion USD | 2.46% |
| 2016 FY | 1.51 Billion USD | 32.44% |
| 2016 Q2 | 1.17 Billion USD | 0.23% |
| 2015 Q2 | 1.07 Billion USD | -0.1% |
| 2015 Q1 | 1.07 Billion USD | -6.42% |
| 2015 FY | 1.14 Billion USD | -1.03% |
| 2015 Q4 | 1.14 Billion USD | 62.56% |
| 2015 Q3 | 701.9 Million USD | -34.88% |
| 2014 Q1 | 1.46 Billion USD | 25.93% |
| 2014 Q3 | 1.28 Billion USD | -6.32% |
| 2014 FY | 1.15 Billion USD | -1.14% |
| 2014 Q4 | 1.15 Billion USD | -9.99% |
| 2014 Q2 | 1.36 Billion USD | -6.91% |
| 2013 Q4 | 1.16 Billion USD | -18.78% |
| 2013 Q1 | 1.52 Billion USD | 24.64% |
| 2013 Q2 | 1.54 Billion USD | 1.16% |
| 2013 Q3 | 1.43 Billion USD | -6.82% |
| 2013 FY | 1.16 Billion USD | -4.57% |
| 2012 FY | 1.22 Billion USD | -17.98% |
| 2012 Q1 | 1.48 Billion USD | -16.16% |
| 2012 Q2 | 1.72 Billion USD | 16.43% |
| 2012 Q3 | 1.64 Billion USD | -4.38% |
| 2012 Q4 | 1.22 Billion USD | -25.9% |
| 2011 FY | 1.49 Billion USD | 146.68% |
| 2011 Q4 | 1.76 Billion USD | -1.52% |
| 2011 Q3 | 1.79 Billion USD | 170.43% |
| 2011 Q2 | 663.37 Million USD | -0.06% |
| 2011 Q1 | 663.74 Million USD | 8.5% |
| 2010 Q3 | 599.66 Million USD | 26.27% |
| 2010 Q2 | 474.9 Million USD | -0.34% |
| 2010 FY | 604.01 Million USD | 56.02% |
| 2010 Q4 | 611.76 Million USD | 2.02% |
| 2010 Q1 | 476.51 Million USD | 1.53% |
| 2009 Q1 | 486.45 Million USD | 8.23% |
| 2009 Q3 | 154.84 Million USD | 6.09% |
| 2009 Q4 | 469.32 Million USD | 203.1% |
| 2009 FY | 387.15 Million USD | -13.87% |
| 2009 Q2 | 145.94 Million USD | -70.0% |
| 2008 Q2 | 581.5 Million USD | -1.88% |
| 2008 Q3 | 404.51 Million USD | -30.44% |
| 2008 Q4 | 449.47 Million USD | 11.11% |
| 2008 FY | 449.47 Million USD | -7.0% |
| 2008 Q1 | 592.63 Million USD | 22.62% |
| 2007 FY | 483.3 Million USD | 30.57% |
| 2007 Q1 | 423.11 Million USD | 14.31% |
| 2007 Q2 | 402.22 Million USD | -4.94% |
| 2007 Q4 | 483.3 Million USD | -3.86% |
| 2007 Q3 | 502.68 Million USD | 24.98% |
| 2006 Q1 | 664.64 Million USD | -2.59% |
| 2006 Q2 | 802.02 Million USD | 20.67% |
| 2006 Q3 | 772.31 Million USD | -3.7% |
| 2006 Q4 | 370.15 Million USD | -52.07% |
| 2006 FY | 370.15 Million USD | -45.75% |
| 2005 Q1 | 770.63 Million USD | -9.64% |
| 2005 FY | 682.31 Million USD | -19.99% |
| 2005 Q3 | 750.87 Million USD | 3.23% |
| 2005 Q4 | 682.31 Million USD | -9.13% |
| 2005 Q2 | 727.36 Million USD | -5.62% |
| 2004 FY | 852.81 Million USD | 5.0% |
| 2004 Q1 | 810.23 Million USD | -0.24% |
| 2004 Q2 | 794.66 Million USD | -1.92% |
| 2004 Q3 | 804.43 Million USD | 1.23% |
| 2004 Q4 | 852.81 Million USD | 6.01% |
| 2003 FY | 812.17 Million USD | 4.88% |
| 2003 Q4 | 812.17 Million USD | 0.76% |
| 2003 Q3 | 806.08 Million USD | -2.92% |
| 2003 Q2 | 830.33 Million USD | 3.53% |
| 2003 Q1 | 802.04 Million USD | 3.57% |
| 2002 Q2 | 796.03 Million USD | 8.04% |
| 2002 FY | 774.37 Million USD | 5.91% |
| 2002 Q1 | 736.79 Million USD | 0.77% |
| 2002 Q4 | 774.37 Million USD | -0.8% |
| 2002 Q3 | 780.65 Million USD | -1.93% |
| 2001 Q3 | 344.2 Million USD | 0.76% |
| 2001 Q1 | 273.62 Million USD | 148.09% |
| 2001 FY | 731.15 Million USD | 562.92% |
| 2001 Q2 | 341.59 Million USD | 24.84% |
| 2001 Q4 | 731.15 Million USD | 112.42% |
| 2000 Q4 | 110.29 Million USD | -12.61% |
| 2000 Q2 | 141.8 Million USD | -6.91% |
| 2000 Q1 | 152.32 Million USD | -7.96% |
| 2000 FY | 110.29 Million USD | -33.36% |
| 2000 Q3 | 126.2 Million USD | -11.0% |
| 1999 FY | 165.5 Million USD | -29.21% |
| 1999 Q3 | 194.2 Million USD | -12.21% |
| 1999 Q4 | 165.5 Million USD | -14.78% |
| 1999 Q1 | 232.6 Million USD | -0.51% |
| 1999 Q2 | 221.2 Million USD | -4.9% |
| 1998 Q2 | 209 Million USD | 44.24% |
| 1998 Q4 | 233.8 Million USD | 11.76% |
| 1998 Q3 | 209.2 Million USD | 0.1% |
| 1998 Q1 | 144.9 Million USD | 11.89% |
| 1998 FY | 233.8 Million USD | 80.54% |
| 1997 FY | 129.5 Million USD | 27.21% |
| 1997 Q1 | 162.3 Million USD | 59.43% |
| 1997 Q2 | 147.3 Million USD | -9.24% |
| 1997 Q3 | 143.9 Million USD | -2.31% |
| 1997 Q4 | 129.5 Million USD | -10.01% |
| 1996 Q1 | 131.4 Million USD | 72.21% |
| 1996 FY | 101.8 Million USD | 33.42% |
| 1996 Q2 | 120.3 Million USD | -8.45% |
| 1996 Q3 | 114.6 Million USD | -4.74% |
| 1996 Q4 | 101.8 Million USD | -11.17% |
| 1995 Q3 | 103 Million USD | -12.71% |
| 1995 Q2 | 118 Million USD | 91.87% |
| 1995 FY | 76.3 Million USD | 248.4% |
| 1995 Q4 | 76.3 Million USD | -25.92% |
| 1995 Q1 | 61.5 Million USD | 180.82% |
| 1994 FY | 21.9 Million USD | -82.37% |
| 1994 Q1 | 102.8 Million USD | -17.23% |
| 1994 Q2 | 85.9 Million USD | -16.44% |
| 1994 Q3 | 71.2 Million USD | -17.11% |
| 1994 Q4 | 21.9 Million USD | -69.24% |
| 1993 Q3 | 222.5 Million USD | -3.39% |
| 1993 FY | 124.2 Million USD | 756.55% |
| 1993 Q1 | 12.7 Million USD | -27.43% |
| 1993 Q2 | 230.3 Million USD | 1713.39% |
| 1993 Q4 | 124.2 Million USD | -44.18% |
| 1992 Q2 | 10.1 Million USD | -30.34% |
| 1992 Q3 | 14.4 Million USD | 42.57% |
| 1992 Q1 | 14.5 Million USD | 40.78% |
| 1992 FY | 14.5 Million USD | -53.38% |
| 1992 Q4 | 17.5 Million USD | 21.53% |
| 1991 Q2 | 30.1 Million USD | -3.22% |
| 1991 FY | 31.1 Million USD | 445.61% |
| 1991 Q3 | 24.1 Million USD | -19.93% |
| 1991 Q4 | 10.3 Million USD | -57.26% |
| 1991 Q1 | 31.1 Million USD | -22.25% |
| 1990 Q1 | 5.7 Million USD | -13.64% |
| 1990 FY | 5.7 Million USD | 256.25% |
| 1990 Q2 | - USD | -100.0% |
| 1990 Q3 | 38.9 Million USD | 0.0% |
| 1990 Q4 | 40 Million USD | 2.83% |
| 1989 Q1 | 1.6 Million USD | 0.0% |
| 1989 FY | 1.6 Million USD | -11.11% |
| 1989 Q3 | 7 Million USD | 0.0% |
| 1989 Q2 | 7 Million USD | 337.5% |
| 1989 Q4 | 6.6 Million USD | -5.71% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | -2582.426% |
| AngioDynamics, Inc. | 5.91 Million USD | -38773.859% |
| AtriCure, Inc. | 74.49 Million USD | -2986.155% |
| Avinger, Inc. | 15.39 Million USD | -14833.42% |
| Azenta, Inc. | 60.43 Million USD | -3704.024% |
| BioLife Solutions, Inc. | 42.69 Million USD | -5285.21% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 10.517% |
| Daxor Corporation | 755.65 Thousand USD | -304137.758% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | -31973.103% |
| Femasys Inc. | 6.7 Million USD | -34208.916% |
| GlucoTrack, Inc. | 196 Thousand USD | -1172859.184% |
| Harvard Bioscience, Inc. | 42.77 Million USD | -5274.886% |
| Hologic, Inc. | 2.53 Billion USD | 9.295% |
| ICU Medical, Inc. | 1.7 Billion USD | -34.861% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -2460.134% |
| KORU Medical Systems, Inc. | 4.44 Million USD | -51619.639% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | -11939.801% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | -137.01% |
| Microbot Medical Inc. | 231 Thousand USD | -995138.095% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -31259.405% |
| Merit Medical Systems, Inc. | 891.35 Million USD | -157.921% |
| Nephros, Inc. | 1.83 Million USD | -125117.865% |
| NovoCure Limited | 596.24 Million USD | -285.582% |
| NEXGEL, Inc. | 2.79 Million USD | -82065.833% |
| NEXGEL, Inc. | 2.79 Million USD | -82065.833% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | -2953.607% |
| OraSure Technologies, Inc. | 13.5 Million USD | -16924.585% |
| Pro-Dex, Inc. | 13.54 Million USD | -16870.547% |
| Pulse Biosciences, Inc. | 9.14 Million USD | -25042.17% |
| Predictive Oncology Inc. | 2.85 Million USD | -80374.263% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | -66839.179% |
| QuidelOrtho Corporation | 2.61 Billion USD | 12.054% |
| Repligen Corporation | 711.8 Million USD | -222.982% |
| Sanara MedTech Inc. | 11.79 Million USD | -19396.087% |
| STAAR Surgical Company | 35.83 Million USD | -6315.695% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -672122.222% |
| Jin Medical International Ltd. | 4.11 Million USD | -55795.94% |